241 related articles for article (PubMed ID: 22448262)
1. Cadmium induces p53-dependent apoptosis in human prostate epithelial cells.
Aimola P; Carmignani M; Volpe AR; Di Benedetto A; Claudio L; Waalkes MP; van Bokhoven A; Tokar EJ; Claudio PP
PLoS One; 2012; 7(3):e33647. PubMed ID: 22448262
[TBL] [Abstract][Full Text] [Related]
2. Acquisition of apoptotic resistance in cadmium-transformed human prostate epithelial cells: Bcl-2 overexpression blocks the activation of JNK signal transduction pathway.
Qu W; Ke H; Pi J; Broderick D; French JE; Webber MM; Waalkes MP
Environ Health Perspect; 2007 Jul; 115(7):1094-100. PubMed ID: 17637928
[TBL] [Abstract][Full Text] [Related]
3. Leptomycin B stabilizes and activates p53 in primary prostatic epithelial cells and induces apoptosis in the LNCaP cell line.
Lecane PS; Kiviharju TM; Sellers RG; Peehl DM
Prostate; 2003 Mar; 54(4):258-67. PubMed ID: 12539224
[TBL] [Abstract][Full Text] [Related]
4. Induction of Plac8 promotes pro-survival function of autophagy in cadmium-induced prostate carcinogenesis.
Kolluru V; Pal D; Papu John AMS; Ankem MK; Freedman JH; Damodaran C
Cancer Lett; 2017 Nov; 408():121-129. PubMed ID: 28844710
[TBL] [Abstract][Full Text] [Related]
5. Altered apoptotic gene expression and acquired apoptotic resistance in cadmium-transformed human prostate epithelial cells.
Achanzar WE; Webber MM; Waalkes MP
Prostate; 2002 Aug; 52(3):236-44. PubMed ID: 12111698
[TBL] [Abstract][Full Text] [Related]
6. MDM-2 antagonists induce p53-dependent cell cycle arrest but not cell death in renal cancer cell lines.
Tsao CC; Corn PG
Cancer Biol Ther; 2010 Dec; 10(12):1315-25. PubMed ID: 20953142
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of de novo purine synthesis in human prostate cells results in ATP depletion, AMPK activation and induces senescence.
Obajimi O; Keen JC; Melera PW
Prostate; 2009 Aug; 69(11):1206-21. PubMed ID: 19434633
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin type 2 receptor-mediated apoptosis of human prostate cancer cells.
Li H; Qi Y; Li C; Braseth LN; Gao Y; Shabashvili AE; Katovich MJ; Sumners C
Mol Cancer Ther; 2009 Dec; 8(12):3255-65. PubMed ID: 19996275
[TBL] [Abstract][Full Text] [Related]
9. Berberine inhibits p53-dependent cell growth through induction of apoptosis of prostate cancer cells.
Choi MS; Oh JH; Kim SM; Jung HY; Yoo HS; Lee YM; Moon DC; Han SB; Hong JT
Int J Oncol; 2009 May; 34(5):1221-30. PubMed ID: 19360335
[TBL] [Abstract][Full Text] [Related]
10. p53-dependent induction of prostate cancer cell senescence by the PIM1 protein kinase.
Zemskova M; Lilly MB; Lin YW; Song JH; Kraft AS
Mol Cancer Res; 2010 Aug; 8(8):1126-41. PubMed ID: 20647331
[TBL] [Abstract][Full Text] [Related]
11. Annexin-A7 protects normal prostate cells and induces distinct patterns of RB-associated cytotoxicity in androgen-sensitive and -resistant prostate cancer cells.
Torosyan Y; Simakova O; Naga S; Mezhevaya K; Leighton X; Diaz J; Huang W; Pollard H; Srivastava M
Int J Cancer; 2009 Dec; 125(11):2528-39. PubMed ID: 19610065
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of prostate cancer cell growth by human secreted PDZ domain-containing protein 2, a potential autocrine prostate tumor suppressor.
Tam CW; Cheng AS; Ma RY; Yao KM; Shiu SY
Endocrinology; 2006 Nov; 147(11):5023-33. PubMed ID: 16873542
[TBL] [Abstract][Full Text] [Related]
13. Nutlin-3 radiosensitizes hypoxic prostate cancer cells independent of p53.
Supiot S; Hill RP; Bristow RG
Mol Cancer Ther; 2008 Apr; 7(4):993-9. PubMed ID: 18413812
[TBL] [Abstract][Full Text] [Related]
14. p53 mutant-type in human prostate cancer cells determines the sensitivity to phenethyl isothiocyanate induced growth inhibition.
Aggarwal M; Saxena R; Asif N; Sinclair E; Tan J; Cruz I; Berry D; Kallakury B; Pham Q; Wang TTY; Chung FL
J Exp Clin Cancer Res; 2019 Jul; 38(1):307. PubMed ID: 31307507
[TBL] [Abstract][Full Text] [Related]
15. Persistent p21Cip1 induction mediates G(1) cell cycle arrest by methylseleninic acid in DU145 prostate cancer cells.
Wang Z; Lee HJ; Chai Y; Hu H; Wang L; Zhang Y; Jiang C; Lü J
Curr Cancer Drug Targets; 2010 May; 10(3):307-18. PubMed ID: 20370687
[TBL] [Abstract][Full Text] [Related]
16. VMY-1-103, a dansylated analog of purvalanol B, induces caspase-3-dependent apoptosis in LNCaP prostate cancer cells.
Ringer L; Sirajuddin P; Yenugonda VM; Ghosh A; Divito K; Trabosh V; Patel Y; Brophy A; Grindrod S; Lisanti MP; Rosenthal D; Brown ML; Avantaggiati ML; Rodriguez O; Albanese C
Cancer Biol Ther; 2010 Aug; 10(4):320-5. PubMed ID: 20574155
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of autophagy prevents cadmium-induced prostate carcinogenesis.
Pal D; Suman S; Kolluru V; Sears S; Das TP; Alatassi H; Ankem MK; Freedman JH; Damodaran C
Br J Cancer; 2017 Jun; 117(1):56-64. PubMed ID: 28588318
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of antagonists of growth hormone releasing hormone on experimental prostate cancers are associated with upregulation of wild-type p53 and decrease in p21 and mutant p53 proteins.
Stangelberger A; Schally AV; Rick FG; Varga JL; Baker B; Zarandi M; Halmos G
Prostate; 2012 Apr; 72(5):555-65. PubMed ID: 21796649
[TBL] [Abstract][Full Text] [Related]
19. Activation of p53/p21Waf1/Cip1 pathway by 5-aza-2'-deoxycytidine inhibits cell proliferation, induces pro-apoptotic genes and mitogen-activated protein kinases in human prostate cancer cells.
Pulukuri SM; Rao JS
Int J Oncol; 2005 Apr; 26(4):863-71. PubMed ID: 15753979
[TBL] [Abstract][Full Text] [Related]
20. Selective COX-2 inhibitor (celecoxib) decreases cellular growth in prostate cancer cell lines independent of p53.
Katkoori VR; Manne K; Vital-Reyes VS; Rodríguez-Burford C; Shanmugam C; Sthanam M; Manne U; Chatla C; Abdulkadir SA; Grizzle WE
Biotech Histochem; 2013 Jan; 88(1):38-46. PubMed ID: 23167625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
